Optimizing G6PD testing for Plasmodium vivax case management: Why sex, counseling, and community engagement matter
© 2020 Chu CS et al. Safe access to the most effective treatment options for Plasmodium vivax malaria are limited by the absence of accurate point-of-care testing to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common human genetic disorder. G6PD-deficient patients are at ris...
Saved in:
Main Authors: | Cindy S. Chu, Germana Bancone, Maureen Kelley, Nicole Advani, Gonzalo J. Domingo, Eva M. Cutiongo-de la Paz, Nicole van der Merwe, Jessica Cohen, Emily Gerth-Guyette |
---|---|
Other Authors: | University of the Philippines Manila |
Format: | Review |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/59007 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Point-of-care testing for G6PD deficiency: Opportunities for screening
by: Athena Anderle, et al.
Published: (2019) -
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
by: Germana Bancone, et al.
Published: (2022) -
Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression
by: Michael Kalnoky, et al.
Published: (2019) -
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood
by: Germana Bancone, et al.
Published: (2019) -
Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests
by: Germana Bancone, et al.
Published: (2018)